Businesses with distributed offices may prefer the cloud-hosted version where they remotely monitor each network by installing PRTG probes in them. This is a subscription service, ...

EDT Portage Biotech (PRTG) trading halted, volatility trading pauseDon't Miss Our End of Quarter Offers: Discover the latest stocks ...

Portage Biotech unveils new preclinical data on PORT-7, showing strong antitumor effects in mesothelioma and advancing plans for clinical trials.

About Portage Biotech Portage Biotech is a clinical-stage immuno-oncology company advancing a pipeline of novel biologics to transform the immune system’s ability to fight cancer. For more information ...

Portage Biotech Inc., a clinical stage immune-oncology company, engages in the research and develops pharmaceutical and biotechnology products. Its product pipeline comprises PORT-8, a dual ...

Portage Biotech has a beta of 1.29, suggesting that its stock price is 29% more volatile than the S&P 500. Comparatively, Cytokinetics has a beta of 0.95, suggesting that its stock price is 5% ...

Investors may trade in the Pre-Market (4:00-9:30 a.m. ET) and the After Hours Market (4:00-8:00 p.m. ET). Participation from Market Makers and ECNs is strictly voluntary and as a result, these ...

There are no SEC filings that match your filter(s), please update your selections to return more records. Nasdaq provides company’s SEC filings, which are financial statements and reports filed ...

Through Paessler GmbH's PRTG software, solution providers have deeper insights with a holistic view into their customers' IT and OT environments. This helps increase their value, builds stronger ...

DOVER, Del., March 12, 2025 (GLOBE NEWSWIRE) -- Portage Biotech Inc. (“Portage” or the “Company”) (NASDAQ: PRTG), a clinical-stage immuno-oncology company with a portfolio of innovative therapeutics, ...